MAIA BIOTECHNOLOGY ANNOUNCES CLINICAL SUPPLY AGREEMENT WITH BEIGENE FOR UPCOMING PHASE 2 TRIALS IN THREE CANCER INDICATIONS

Reuters · 01/07 14:12

Please log in to view news